CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice

Authors: Daniel Stone, Kelly R. Long, Michelle A. Loprieno, Harshana S. De Silva Feelixge, Elizabeth J. Kenkel, R. Matt Liley, Stephen Rapp, Pavitra Roychoudhury, Thuy Nguyen, Laurence Stensland, Rossana Colón-Thillet, Lindsay M. Klouser, Nicholas D. Weber, Connie Le, Jessica Wagoner, Erin A. Goecker, Alvason Zhenhua Li, Karsten Eichholz, Lawrence Corey, D. Lorne Tyrrell, Alexander L. Greninger, Meei-Li Huang, Stephen J. Polyak, Martine Aubert, John E. Sagartz, Keith R. Jerome

Source: Molecular Therapy: Methods & Clinical Development, Vol 20, Iss , Pp 258-275 (2021)

Subject Terms: HBV, AAV, Gene editing, Humanized mouse, CRISPR/Cas9, Genetics, QH426-470, Cytology, QH573-671

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2329050120302412; https://doaj.org/toc/2329-0501

Access URL: https://doaj.org/article/50136f1751074d8594ac5811c80e88ea